Insight Molecular Diagnostics (IMDX) Deferred Taxes (2020 - 2021)
Insight Molecular Diagnostics (IMDX) posted Deferred Taxes of $97000.0 for Q4 2021, up 105.41% sequentially from -$1.8 million in Q2 2021, and up 161.01% YoY from $37163.9 in Q4 2020.
Insight Molecular Diagnostics (IMDX) Deferred Taxes (2020 - 2021) Analysis & Trends
Insight Molecular Diagnostics has reported Deferred Taxes for 2 years, with the latest figure at $97000.0 in Q4 2021.
- Quarterly Deferred Taxes rose 161.01% year-over-year to $97000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was -$9.3 million (down 638.52% YoY) and the FY2021 annual result came in at -$9.3 million, down 638.52% from the prior year.
- Deferred Taxes rose to $97000.0 in Q4 2021 per IMDX's latest filing, from -$1.8 million in the prior quarter.
- Over five years, Deferred Taxes peaked at $97000.0 in Q4 2021 and troughed at -$7.6 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | -208.00 Mn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 6.54 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 32.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -36.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | - |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -21.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 1.82 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -2.00 Mn |
| 10 | Insight Molecular Diagnostics | 172.42 Mn | 143.49 Mn | 15,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 97,000.00 |
| Jun 30, 2021 | -1.79 Mn |
| Mar 31, 2021 | -7.56 Mn |
| Dec 31, 2020 | -159,000.00 |
| Mar 31, 2020 | -1.10 Mn |